Signaturefd, LLC Karuna Therapeutics, Inc. Transaction History

Signaturefd, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$161.01 - $317.85 $34,134 - $67,384	212 Added 77.09%	487 $154,000
Q3 2023 Nov 03, 2023	BUY	$164.66 - $218.08 $32,932 - $43,616	200 Added 266.67%	275 $46,000
Q2 2023 Aug 01, 2023	BUY	$176.32 - $240.22 $3,702 - $5,044	21 Added 38.89%	75 $16,000
Q1 2023 Apr 28, 2023	SELL	$161.33 - $204.36 $645 - $817	-4 Reduced 6.9%	54 $9,000
Q4 2022 Jan 27, 2023	BUY	$191.53 - $236.82 $383 - $473	2 Added 3.57%	58 $11,000
Q3 2022 Nov 08, 2022	BUY	$123.79 - $277.42 $2,475 - $5,548	20 Added 55.56%	56 $13,000
Q2 2022 Aug 10, 2022	BUY	$93.97 - $143.33 $187 - $286	2 Added 5.88%	36 $5,000
Q1 2022 May 02, 2022	BUY	$98.9 - $132.37 $2,670 - $3,573	27 Added 385.71%	34 $4,000
Q3 2021 Oct 28, 2021	BUY	$101.2 - $125.87 $708 - $881	7 New	7 $1,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.